✦ LIBER ✦

Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients

✍ Scribed by Yoshihiro Nakagami; Makoto Ohori; Noboru Sakamoto; Shoji Koga; Riu Hamada; Tadashi Hatano; Masaaki Tachibana

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel, low-dose estramustine, and do

✍ Yoshihiro Wada; Ken Kikuchi; Wataru Takahashi; Jiro Honda; Juro Nakanishi; Koich 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 409 KB

Combination chemotherapy with weekly doc

✍ Atsushi Takenaka; Yuji Yamada; Toshifumi Kurahashi; Hideo Soga; Hideaki Miyake; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Evaluation of docetaxel plus estramustin

✍ Akihiro Matsumoto; Atsushi Inoue; Satoshi Yokoi; Kazuyoshi Nozumi; Kanetaka Miya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Monthly paclitaxel and carboplatin with

✍ Takehiko Segawa; Toshiyuki Kamoto; Hidefumi Kinoshita; Yasuharu Kunishima; Koji 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 378 KB

Docetaxel and zoledronic acid in patient

✍ Dimitri Vordos; Bernard Paule; Francis Vacherot; Yves Allory; Laurent Salomon; A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Dramatic decline in prostate-specific an

✍ MIZUKI KOBAYASHI; HIROSHI KURAMOTO; JUNICHIRO OTA; NAOHIRO FUJIMOTO 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB